Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strategies for Switching from Amitriptyline to Duloxetine in DPNP
NCT00266643Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of duloxetine in diabetic polyneuropathy (DPN), sponsored by Eli Lilly and Company. Started Dec 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT00266643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266643.